Megan Munsie

Prof. Megan Munsie

orcid

Research Focus & Metrics

Academic Career Length

30Years (1997-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 June 2021 in Stem Cell Reports
Verified
Journal Article
Open access
RLRobin Lovell-Badge
Robin Lovell-Badge
EAEric Anthony
Eric Anthony
RBRoger A. Barker
Roger A. Barker
TBTania Bubela
Tania Bubela
ABAli H. Brivanlou
Ali H. Brivanlou
XZXiaomei Zhai
Xiaomei Zhai
The International Society for Stem Cell Research has updated its Guidelines for Stem Cell Research and Clinical Translation in order to address advances in stem cell science and other relevant fields, together with the associated ethical, social, and policy issues that have arisen since the last update in 2016. While growing to encompass the evolving science, clinical applications of stem cells, and the increasingly complex implications of stem cell research for society, the basic principles underlying the Guidelines remain unchanged, and they will continue to serve as the standard for the field and as a resource for scientists, regulators, funders, physicians, and members of the public, including patients. A summary of the key updates and issues is presented here.

1 August 2000 in Current Biology
Verified
Journal Article
Closed access
MMMegan Munsie
Megan Munsie
AMAnna E. Michalska
Anna E. Michalska
COCarmel M. O’brien
Carmel M. O’brien
Alan TrounsonAlan Trounson
Alan Trounson
MPMartin F. Pera
Martin F. Pera
PMPeter S. Mountford
Peter S. Mountford

1 June 2016 in Stem Cell Reports
Verified
Journal Article
Open access
GDGeorge Q. Daley
George Q. Daley
IHInsoo Hyun
Insoo Hyun
JAJane F. Apperley
Jane F. Apperley
RBRoger A. Barker
Roger A. Barker
NBNissim Benvenisty
Nissim Benvenisty
JKJonathan Kimmelman
Jonathan Kimmelman
The International Society for Stem Cell Research (ISSCR) presents its 2016 Guidelines for Stem Cell Research and Clinical Translation (ISSCR, 2016). The 2016 guidelines reflect the revision and extension of two past sets of guidelines (ISSCR, 2006; ISSCR, 2008) to address new and emerging areas of stem cell discovery and application and evolving ethical, social, and policy challenges. These guidelines provide an integrated set of principles and best practices to drive progress in basic, translational, and clinical research. The guidelines demand rigor, oversight, and transparency in all aspects of practice, providing confidence to practitioners and public alike that stem cell science can proceed efficiently and remain responsive to public and patient interests. Here, we highlight key elements and recommendations in the guidelines and summarize the recommendations and deliberations behind them.

1 December 2008 in Cell Stem Cell
Verified
Journal Article
Closed access
IHInsoo Hyun
Insoo Hyun
OLOlle Lindvall
Olle Lindvall
LÄLars Ährlund-Richter
Lars Ährlund-Richter
ECElena Cattaneo
Elena Cattaneo
MCMarina Cavazzana
Marina Cavazzana
GDGeorge Q. Daley
George Q. Daley

5 July 2017 in Science Translational Medicine
Verified
Journal Article
Closed access
PDF file
DSDouglas Sipp
Douglas Sipp
TCTimothy Caulfield
Timothy Caulfield
JKJane Kaye
Jane Kaye
JBJan Barfoot
Jan Barfoot
CBClare Blackburn
Clare Blackburn
JRJohn E.J. Rasko
John E.J. Rasko
Commercial promotion of unsupported therapeutic uses of stem cells is a global problem that should be addressed by coordinated approaches at the national and international levels.

15 March 2017 in Development
Verified
Journal Article
Open access
PDF file
MMMegan Munsie
Megan Munsie
IHInsoo Hyun
Insoo Hyun
JSJeremy Sugarman
Jeremy Sugarman
Research involving human organoids and gastruloids involves ethical issues associated with their derivation as well as their current and future uses. These include unique issues related to the extent of maturation that can be achieved in vitro or through chimeric research, as well as fundamental ethical considerations such as those concerning the provenance of human biomaterials and the use of gene-editing technologies. Many of these issues are not specifically addressed by existing ethics oversight mechanisms, but these mechanisms might be easily extended to help ensure that human organoid and related research moves forward in an ethically appropriate manner.